Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain ...

Retrieved on: 2021-01-12 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Merck pulls close to Pfizer in next-gen pneumococcal vaccine race as FDA fast-tracks 15-strain .... View article details on hiswai:

Excerpt

Pfizer's $5.8 billion-a-year Prevnar 13 is one of the company's top blockbusters and the undisputed leader in the market for pneumococcal vaccines.

Article found on: www.fiercepharma.com